PR Home October 29, 2014

eClinicalWorks Chooses Exostar’s New Identity Proofing and Second Factor Credential Authentication Service

ProviderPass Meets Security and Regulatory Compliance Requirements Necessary for Electronic Prescribing of Controlled Substances

HERNDON, VA, and WESTBOROUGH, MA – Exostar, an innovative information technology company offering cloud-based solutions that enable secure, cost-effective business-to-business collaboration, today announced the general availability of its new turn-key, Software-as-a-Service (SaaS) identity proofing and second factor credential authentication solution, ProviderPass. eClinicalWorks, a leader in ambulatory healthcare IT solutions, has selected ProviderPass to expand its comprehensive electronic health records (EHR) product suiteto include electronic prescribing of controlled substances (EPCS).

The Drug Enforcement Administration (DEA) created strict technical EPCS requirements to help combat the prescription drug abuse epidemic. Healthcare providers who wish to e-prescribe controlled substances must complete a stringent identity proofing process and present a high-assurance digital credential to verify their identity and digital signature when they submit a prescription.
With ProviderPass, eClinicalWorks will deliver easy-to-use, innovative, affordable EPCS functionality to its customers, which include large hospital systems; large and small health systems; large, medium, small, and solo provider practices; correctional health services; and community health centers throughout the U.S.

“We wanted to deploy an EPCS capability that preserved a consistent end-user experience for our customers and met current and anticipated DEA requirements,” said Jinesh Gandhi, partner operations at eClinicalWorks. “Exostar’s legacy in the aerospace and defense industry, known for the depth and breadth of its security and compliance requirements, was a critical factor in our decision. That, along with their turn-key SaaS business model and proven track record credentialing organizations with tens of thousands of users, gave us confidence we would meet our objectives and obtain a competitive advantage.”

Exostar’s ProviderPass includes remote identity proofing conducted in conjunction with Experian or via live web cam video. Individuals purchase a one-time password (OTP) hardware token through Exostar’s web store. eClinicalWorks customers use its EHR system in tandem with an activated OTP token to seamlessly e-prescribe controlled substances.

Exostar is a full-service Credential Service Provider certified by the SAFE-BioPharma Association to meet the National Institute of Standards and Technology’s 800-63 Level 3 standard mandated by the DEA. Because SAFE-BioPharma is a U.S. Government-approved Trust Framework Provider, ProviderPass also aligns with U.S. Federal Identity and Credentialing Access Management (FICAM) requirements.

“eClinicalWorks clearly understands how EPCS simultaneously can improve patient outcomes, mitigate the illicit distribution of controlled substances, and enable providers to more efficiently and effectively focus on patient care,” said Vijay Takanti, Exostar’s Vice President of Security and Collaboration Solutions. “We believe other health IT vendors will follow the lead of eClinicalWorks and turn to our ProviderPass service offering to enhance the security of their EHR solutions for EPCS and other use cases where identity verification and information protection are priorities.”